Spironolactone and Urinary bladder haemorrhage - a phase IV clinical study of FDA data

Summary:

Urinary bladder haemorrhage is reported as a side effect among people who take Spironolactone (spironolactone), especially for people who are male, 60+ old, also take Eliquis, and have Pulmonary embolism.

The phase IV clinical study analyzes which people have Urinary bladder haemorrhage when taking Spironolactone. It is created by eHealthMe based on reports of 119,147 people who have side effects when taking Spironolactone from the FDA, and is updated regularly.

What is Spironolactone?

Spironolactone has active ingredients of spironolactone. It is often used in acne. eHealthMe is studying from 122,947 Spironolactone users. Check the latest studies of Spironolactone.

What is Urinary bladder haemorrhage?

Urinary bladder haemorrhage (urinary bladder bleeding) is found to be associated with 289 drugs and 465 conditions by eHealthMe. Check the latest studies of Urinary bladder haemorrhage.

On Jul, 08, 2026

119,147 people reported to have side effects when taking Spironolactone.
Among them, 40 people (0.03%) have Urinary bladder haemorrhage.

Could Spironolactone cause Urinary bladder haemorrhage?

Among these 40 people:

What is the gender of people who have Urinary bladder haemorrhage when taking Spironolactone? *

female: 5.13 %
male: 94.87 %

What is the age of people who have Urinary bladder haemorrhage when taking Spironolactone? *

What are other drugs people take besides Spironolactone? *

What are other side effects people have besides Urinary bladder haemorrhage? *

Haematuria (presence of blood in urine): 29 people, 72.50%
Hypotension (abnormally low blood pressure): 24 people, 60.00%
Ventricular Fibrillation (abnormally irregular heart rhythm): 21 people, 52.50%
Haematoma (collection of blood outside the blood vessels): 21 people, 52.50%
Haemothorax (collection of blood in the pleural space (the space between the lungs and the walls of the chest)): 21 people, 52.50%
Thrombosis (formation of a blood clot inside a blood vessel): 21 people, 52.50%
Mouth Haemorrhage (bleeding from mouth): 21 people, 52.50%
Death: 20 people, 50.00%
Abdominal Distension: 3 people, 7.50%
Pleural Effusion (water on the lungs): 3 people, 7.50%

What are the existing conditions these people have? *

Pulmonary Embolism (blockage of the main artery of the lung): 21 people, 52.50%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 4 people, 10.00%
Blood Iron Increased: 2 people, 5.00%
Thrombosis (formation of a blood clot inside a blood vessel): 1 person, 2.50%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 1 person, 2.50%
Asthma: 1 person, 2.50%
Carcinoid Tumor: 1 person, 2.50%
Cardiac Failure: 1 person, 2.50%
Cardiac Failure Chronic: 1 person, 2.50%
Cataract (clouding of the lens inside the eye): 1 person, 2.50%

* Approximation only. Some reports may have incomplete information.

Do you take Spironolactone and have Urinary bladder haemorrhage?

- Check whether Urinary bladder haemorrhage is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Spironolactone:

Spironolactone (122,947 reports)

Browse all side effects of Spironolactone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Urinary bladder haemorrhage:

Urinary bladder haemorrhage (289 drugs)

Browse all the conditions that are associated with Urinary bladder haemorrhage:

Urinary bladder haemorrhage (465 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on spironolactone (the active ingredients of Spironolactone) and Spironolactone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.